ALLISON RUDD: Open Payments
NPI 1447810825 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 47 payments from 10 companies in 2025. Trend: 2023 $335 · 2024 $1,041 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $430 |
| Galderma Laboratories, L.P. | 8 | $243 |
| PFIZER INC. | 7 | $194 |
| GENZYME CORPORATION | 1 | $122 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| Lilly USA, LLC | 2 | $47 |
| UCB, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Amgen Inc. | 1 | $25 |
| LEO Pharma Inc. | 1 | $15 |
Products named: SKYRIZI, NEMLUVIO, LITFULO, DUPIXENT, CIBINQO, ILUMYA, Bimzelx, COSENTYX.
Industry payments across FL — which companies pay providers there.
